Ramelteon (Rozerem)

Indications

Prevention of Intensive Care Unit-Associated Delirium (see Delirium, [[Delirium]])

  • Clinical Efficacy
    • Trial of Ramelteon (Melatonin Agonist) on the Development of Delirium in Elderly (Age 65-89) Hospitalized Patients (JAMA Psychiatry, 2014) [MEDLINE]
      • Ramelteon Decreased the Incidence of Delirium

Pharmacology

  • Melatonin Agonist

Metabolism

  • xxxx

Administration

  • xxxx

Dose Adjustment

  • Hepatic:
  • Renal:

Adverse Effects

Other Adverse Effects

  • xxx
  • xxx
  • xxx

References

  • Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014 Apr;71(4):397-403. doi: 10.1001/jamapsychiatry.2013.3320 [MEDLINE]